INIFY Laboratories AB (OSL:INIFY)
Norway · Delayed Price · Currency is NOK 5.40
-0.05 (-0.92%)
At close: Oct 2, 2025
INIFY Laboratories AB Market Cap
INIFY Laboratories AB has a market cap or net worth of 469.48 million as of October 3, 2025. Its market cap has increased by 48.26% in one year.
Market Cap
469.48M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.40
Market Cap Chart
Since June 20, 2022, INIFY Laboratories AB's market cap has increased from 452.37M to 469.48M, an increase of 3.78%. That is a compound annual growth rate of 1.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 469.48M | 24.46% |
| Dec 30, 2024 | 377.20M | -32.76% |
| Dec 29, 2023 | 560.94M | 72.20% |
| Dec 30, 2022 | 325.75M | -27.99% |
| Jun 20, 2022 | 452.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.11B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 1.58B |
| ArcticZymes Technologies ASA | 1.38B |
| Thor Medical ASA | 1.24B |
| Omda AS | 1.04B |
| Vistin Pharma ASA | 1.01B |
| Gentian Diagnostics ASA | 848.23M |